Met nsclc w/ egfr alk oth ab
Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement
curl https://api.healthcare.dev/v1/codes/hcpcs/M1412 \ -H "Authorization: Bearer $HDEV_API_KEY"
{
"data": {
"code": "M1412",
"parent": null,
"status": "active",
"system": "hcpcs",
"display": "Met nsclc w/ egfr alk oth ab",
"billable": true,
"attributes": {
"betos": "Z2",
"coverage": "C",
"action_code": "N",
"type_of_service": "1",
"pricing_indicator": "00",
"action_effective_date": "2025-01-01"
},
"description": "Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement",
"replaced_by": [],
"effective_end": null,
"effective_start": "2025-01-01",
"care_categories": [],
"care_category_details": []
},
"meta": {
"source": "cms-hcpcs",
"data_version": "2026-10"
}
}CMS attributes
Change history
M1412 has been in effect since 2025-01-01. This page shows HCPCS Level II release 2026-10.
Add as_of=YYYY-MM-DD to the request to get this code exactly as it was on a past date. The change feed (GET /v1/changes) lists what each release added, changed or retired across the whole dataset; a per-code change list isn't published yet.
Use it
curl https://api.healthcare.dev/v1/codes/hcpcs/M1412 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up HCPCS Level II code M1412. Tell me what it covers, whether it is active and since when, and any CMS attributes it has.
Source: CMS, release 2026-10. Public domain (D-series CDT codes excluded). Reference data, not medical or billing advice.